These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23810227)

  • 1. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
    Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Llarena M; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; Peña-Quintana L; González D; Sánchez-Valverde F
    Mol Genet Metab; 2015 May; 115(1):10-6. PubMed ID: 25882749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Peña-Quintana L; Ruiz MA; González D; Sánchez-Valverde F
    Clin Nutr; 2014 Aug; 33(4):702-17. PubMed ID: 24120886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for developing mineral bone disease in phenylketonuric patients.
    Mirás A; Bóveda MD; Leis MR; Mera A; Aldámiz-Echevarría L; Fernández-Lorenzo JR; Fraga JM; Couce ML
    Mol Genet Metab; 2013 Mar; 108(3):149-54. PubMed ID: 23352389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.
    Rocha JC; van Spronsen FJ; Almeida MF; Ramos E; Guimarães JT; Borges N
    Mol Genet Metab; 2013; 110 Suppl():S40-3. PubMed ID: 24183791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of physical development in children with classical phenylketonuria].
    Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
    Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy.
    Acosta PB; Yannicelli S; Singh R; Mofidi S; Steiner R; DeVincentis E; Jurecki E; Bernstein L; Gleason S; Chetty M; Rouse B
    J Am Diet Assoc; 2003 Sep; 103(9):1167-73. PubMed ID: 12963945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
    Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
    N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy.
    Lambruschini N; Pérez-Dueñas B; Vilaseca MA; Mas A; Artuch R; Gassió R; Gómez L; Gutiérrez A; Campistol J
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S54-60. PubMed ID: 16040265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies and prediction of long-term responders.
    Hennermann JB; Roloff S; Gebauer C; Vetter B; von Arnim-Baas A; Mönch E
    Mol Genet Metab; 2012 Nov; 107(3):294-301. PubMed ID: 23062575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Blau N; Erlandsen H
    Mol Genet Metab; 2004 Jun; 82(2):101-11. PubMed ID: 15171997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with adolescents with phenylketonuria returned to phenylalanine-restricted diets.
    Hogan SE; Gates RD; MacDonald GW; Clarke JT
    J Am Diet Assoc; 1986 Sep; 86(9):1203-7. PubMed ID: 3745744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin.
    Trefz FK; Scheible D; Frauendienst-Egger G; Korall H; Blau N
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S75-80. PubMed ID: 16242984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria.
    Steinfeld R; Kohlschütter A; Ullrich K; Lukacs Z
    J Inherit Metab Dis; 2004; 27(4):449-53. PubMed ID: 15303001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in growth of phenylketonuric patients.
    Couce ML; Guler I; Anca-Couce A; Lojo M; Mirás A; Leis R; Pérez-Muñuzuri A; Fraga JM; Gude F
    Eur J Pediatr; 2015 May; 174(5):651-9. PubMed ID: 25367055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?
    MacDonald A; Ahring K; Dokoupil K; Gokmen-Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Bélanger-Quintana A
    Br J Nutr; 2011 Jul; 106(2):175-82. PubMed ID: 21466737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment.
    Levy H; Burton B; Cederbaum S; Scriver C
    Mol Genet Metab; 2007 Dec; 92(4):287-91. PubMed ID: 18036498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.